HBV-ACLF vs CHB | HBV-ACLF vs normal | ||||||
---|---|---|---|---|---|---|---|
Cytokine | Gene symbol | Entrez GeneID | Full name | Fold change | q Value | Fold change | q Value |
HGF*† | HGF | 3082 | Hepatocyte growth factor (hepapoietin A, scatter factor) | 35.5 | 0.0097 | 34.2 | 0.0007 |
MIP-3α*† | CCL20 | 6364 | MIP-3α | 9.1 | 0.0078 | 8.2 | 0.0007 |
CEACAM1*† | CEACAM1 | 634 | Carcinoembryonic antigen-related cell adhesion molecule 1 | 5.6 | 0.0136 | 4.7 | 0.0012 |
GDF-15*† | GDF15 | 9518 | Growth differentiation factor 15 | 5.2 | 0.0052 | 3.0 | 0.0007 |
E-selectin*† | SELE | 6401 | Selectin E | 4.9 | 0.0097 | 5.7 | 0.0008 |
Osteopontin*#† | SPP1 | 6696 | Secreted phosphoprotein 1 | 4.3 | 0.0097 | 4.6 | 0.0007 |
Ferritin* | FTMT | 94033 | Ferritin mitochondrial | 2.9 | 0.0151 | 2.3 | 0.0026 |
BCAM† | BCAM | 4059 | Basal cell adhesion molecule (Lutheran blood group) | 2.1 | 0.0104 | 2.4 | 0.0007 |
PSA-total† | KLK3 | 354 | Kallikrein-related peptidase 3 | −2.4 | 0.0097 | −2.3 | 0.0009 |
LHCGR† | LHCGR | 3973 | Luteinising hormone, choriogonadotropin receptor | −1.6 | 0.0078 | −2.0 | 0.0012 |
CD40-ligand† | CD40LG | 959 | CD40 ligand | −1.8 | 0.0052 | −1.6 | 0.0030 |
CD30† | TNFRSF8 | 943 | Tumour necrosis factor receptor superfamily, member 8 | −1.5 | 0.0104 | −1.7 | 0.0009 |
MICB† | MICB | 4277 | MHC class I polypeptide-related sequence B | −1.5 | 0.0097 | −1.4 | 0.0019 |
CA15-3† | MUC1 | 4852 | Mucin 1, cell surface associated | −1.4 | 0.0104 | −1.1 | 0.0127 |
Erythropoietin-R† | EPOR | 2057 | Erythropoietin receptor | −1.4 | 0.0097 | −1.3 | 0.0052 |
*Identified by PAM analyses.
†Identified by SAM analyses.
ACLF, acute-on-chronic liver failure; CHB, chronic hepatitis B; MIP-3α, macrophage inflammatory protein 3α; PAM, predictive analyses of microarrays; SAM, significance analyses of microarrays.